|
Volumn 86, Issue SUPPL. 1, 2001, Pages 4-8
|
Discovery of leukotrienes and development of antileukotriene agents
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1 [2 METHOXY 4 [(PHENYLSULFONYLAMINO)CARBONYL]BENZYL] 1H INDAZOLE 6 CARBAMIC ACID CYCLOPENTYL ESTER;
2 [4 [2 (5 TETRAZOLYLMETHYL)BENZYLOXY]PHENOXYMETHYL]QUINOLINE;
3 [(2 CARBOXYETHYL)THIO] 3 [2 (8 PHENYLOCTYL)PHENYL]PROPIONIC ACID;
4 (4 CARBOXYPHENYLTHIO) 7 [4 (4 PHENOXYBUTOXY)PHENYL] 5 HEPTENOIC ACID;
6 (4 CARBOXYPHENYLTHIO) 5 HYDROXY 7,9,11,14 ICOSATETRAENOIC ACID;
7 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY) 2 HYDROXYPROPOXY] 4 OXO 8 PROPYL 4H 1 BENZOPYRAN 2 CARBOXYLIC ACID;
ARACHIDONATE 5 LIPOXYGENASE;
CGP 45715;
IRALUKAST;
LEUKOTRIENE;
LEUKOTRIENE C4;
LEUKOTRIENE D4;
LEUKOTRIENE E4;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MONTELUKAST;
POBILUKAST;
PRANLUKAST;
SLOW REACTING SUBSTANCE;
TOMELUKAST;
VERLUKAST;
ZAFIRLUKAST;
ZILEUTON;
ASTHMA;
BRONCHUS MUSCLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG MECHANISM;
HUMAN;
MEDIATOR RELEASE;
MUSCLE CONTRACTION;
PATHOGENESIS;
PRIORITY JOURNAL;
SYMPTOMATOLOGY;
|
EID: 0034968081
PISSN: 10811206
EISSN: None
Source Type: Journal
DOI: 10.1016/s1081-1206(10)62305-8 Document Type: Conference Paper |
Times cited : (25)
|
References (39)
|